Socios protectores


VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.

We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received growing customer testimonials and numerous citations in high-impact publications.

Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies.

Custom vectors and viruses

VectorBuilder is the world’s largest provider of custom vectors for both viral and non-viral gene delivery. We currently tailor-build over 80,000 vectors a year for tens of thousands of researchers around the world. Our vector services boast several important advantages:

  • Online vector design and ordering platform.
  • Comprehensive vector systems.
  • Vast vector inventory.

CRO services

Besides custom vectors and viruses, VectorBuilder offers a wide range of CRO services covering many more gene delivery applications in basic research and drug discovery:

  • Diverse gene delivery solutions.
  • Preclinical vector testing.
  • High value-added R&D.

CDMO services

VectorBuilder is a full-service CDMO with extensive experience in cGMP vector manufacturing. Operating several state-of-the-art facilities, we have supported many customers along their entire drug-discovery pipelines, going from research-grade vectors for early discovery, to GMP-like vectors for preclinical testing, to full GMP-grade vectors for clinical trials. We have provided IND-enabling vectors to a worldwide client base in the US, Europe, Japan, China and South Korea. Our CDMO services include process development, analytical development, cell banking, fill/finish and regulatory support. Our GMP manufacturing cover the following systems:

  • Plasmid DNA.
  • Viral vectors.
  • mRNA.

IP out-licensing

With strong R&D capabilities, VectorBuilder has built an extensive IP portfolio of gene delivery technologies, some of which can be out-licensed. These include new AAV serotypes, novel viral G proteins, engineered tissue-specific promoters, high-yield recombinant protein producer cell lines, etc.